CRX.L Regulatory News (CRX)

16 Feb 2007 07:00

Cyprotex PLC16 February 2007 16 February, 2007 Cyprotex PLC (the "Company" or "Cyprotex") Solid progress during 2006 Cyprotex PLC ("the Company") confirms the release date for its 2006 preliminaryresults will be Thursday 15th March 2007. Following release of the preliminaryresults, Chairman and Chief Executive Officer, Mr Robert Morrisson Atwater, willbe available to discuss progress made during 2006 and the outlook for 2007. Cyprotex's preliminary results will outline a further broad expansion of itscustomer base, which accelerated strongly during the second half of the year.These now number well in excess of 100 pharmaceutical companies, biotechs andCROs "Contract Research Organisations", ranging from amongst the top ten globalpharmaceutical companies to smaller specialised drug discovery groups. As well as expanding its customer base, 2006 was also a year of reducing costs,whilst maximising operational gearing and the robustness of the company's highlytechnical operations. Despite investment in its facilities, Cyprotex ended theyear with a good cash reserve and recorded its first modest quarterly net profitduring the final three months of 2006. Cyprotex's management looks to 2007 as a year of further significant progress. For further information: Cyprotex PLCRobert Morrison Atwater, CEOTel: +44 1625 505 100ir@cyprotex.comwww.cyprotex.com or Russell Gibbs, CFOTel: +44 1625 505 100ir@cyprotex.comwww.cyprotex.com Media Enquires: WMC CommunicationsCharlie Geller/Alex GloverTel: +44 (0)20 7930 9030charlie.geller@wmccommunications.com This information is provided by RNS The company news service from the London Stock Exchange